Could a heart pill curb alcohol cravings? new study tests guanfacine via telehealth
NCT ID NCT06629259
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 23 times
Summary
This study tests whether guanfacine, a medicine used for high blood pressure, can help people with alcohol use disorder drink less. Two hundred adults who want to quit drinking will take either guanfacine or a placebo for 12 weeks. Researchers will track drinking days, blood alcohol levels, and stress-related cravings using remote breathalyzers and surveys.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rutgers School of Health Professionals
RECRUITINGNewark, New Jersey, 07107, United States
Contact Email: •••••@•••••
Contact
-
The Stark Neuroscience Building (Goodman Hall)
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.